Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Lien de l’article original :
Bullish on BNB? Windtree Therapeutics unveils $520m funding plan